trial · primary record
NS-863 Low Dose
Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 177 |
| Primary completion | 2028-12-14 |
| Primary endpoint | Change in pulmonary vascular resistance (PVR) at week 24 |
| Registry ID | NCT07441278 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:38.469Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07441278
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.